Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126050671 | 12605067 | 1 | I | 20160725 | 20160728 | 20160728 | EXP | CA-AMGEN-CANSP2016096856 | AMGEN | 18.00 | YR | A | F | Y | 0.00000 | 20160728 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126050671 | 12605067 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 80 MG, UNK | U | 103795 | 80 | MG | UNKNOWN FORMULATION | ||||||
| 126050671 | 12605067 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 8 MG/KG, UNK | 0 | 8 | MG/KG | ||||||||
| 126050671 | 12605067 | 3 | SS | INFLIXIMAB | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126050671 | 12605067 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | TABLET | |||||||
| 126050671 | 12605067 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126050671 | 12605067 | 1 | Rheumatoid arthritis |
| 126050671 | 12605067 | 2 | Rheumatoid arthritis |
| 126050671 | 12605067 | 3 | Rheumatoid arthritis |
| 126050671 | 12605067 | 4 | Rheumatoid arthritis |
| 126050671 | 12605067 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126050671 | 12605067 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126050671 | 12605067 | Amnesia | |
| 126050671 | 12605067 | Condition aggravated | |
| 126050671 | 12605067 | Drug hypersensitivity | |
| 126050671 | 12605067 | Drug ineffective | |
| 126050671 | 12605067 | Drug intolerance | |
| 126050671 | 12605067 | Nausea | |
| 126050671 | 12605067 | Rheumatoid arthritis | |
| 126050671 | 12605067 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |